Teladoc Health, Inc. (NYSE:TDOC) Stock Position Lessened by First Trust Advisors LP

First Trust Advisors LP trimmed its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 79.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,210 shares of the health services provider's stock after selling 48,610 shares during the period. First Trust Advisors LP's holdings in Teladoc Health were worth $111,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Arizona State Retirement System increased its stake in Teladoc Health by 1.8% in the 4th quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider's stock worth $452,000 after buying an additional 859 shares during the period. Canada Pension Plan Investment Board lifted its position in Teladoc Health by 0.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider's stock valued at $2,079,000 after acquiring an additional 1,200 shares during the last quarter. Summit Investment Advisors Inc. increased its position in Teladoc Health by 8.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider's stock valued at $164,000 after buying an additional 1,331 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Teladoc Health by 22.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock valued at $73,000 after purchasing an additional 1,439 shares during the last quarter. Finally, Lindbrook Capital LLC boosted its stake in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after purchasing an additional 1,612 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of research reports. Bank of America lowered their price target on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a research report on Friday, April 11th. Evercore ISI reduced their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a report on Thursday, May 1st. Oppenheimer lowered their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Canaccord Genuity Group cut their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $9.71.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.58% of the company's stock.

Teladoc Health Trading Down 3.9%

Shares of Teladoc Health stock traded down $0.30 during trading hours on Wednesday, reaching $7.32. 4,241,358 shares of the company's stock were exchanged, compared to its average volume of 6,239,371. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The company has a fifty day moving average of $7.68 and a 200-day moving average of $9.40. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.28 billion, a price-to-earnings ratio of -1.27 and a beta of 1.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.